Tandem Diabetes (TNDM) Tops Q4 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus

Go back to Tandem Diabetes (TNDM) Tops Q4 EPS by 22c, Revenues Beat; Offers FY19 Revenue Guidance Above Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 17.55 +0.68 (4.03%)
Previous Close $16.87    52 Week High $12.48 
Open $17.01    52 Week Low $1.60 
Day High $17.66    P/E N/A 
Day Low $16.60    EPS $-6.33 
Volume 661,425